HM Venture Partners is a healthcare venture capital firm based in San Francisco that invests globally, including the United States and China. The firm backs early- and later-stage healthcare companies across biotechnology, medical devices, HealthTech, life sciences, pharmaceuticals and oncology, and has acted as a co-lead investor in a Series A financing. It is relevant for founders building healthcare and life sciences companies seeking venture capital with operational support, clinical network access and cross-border ecosystem reach.